Opinion

Manufacturers: Get ready for global trade account management

March 11, 2015

Partnering to diversify yields rapid growth

March 11, 2015

A family-owned pharmaceutical manufacturer plots a 21st-century growth plan

Drug pricing debate is sharpening

January 29, 2015

Will formularies become a consumer's concern for healthcare provision?

Managing third-party risks in the life sciences industry

January 27, 2015

Internal compliance reviews are not enough; life sciences companies need to assess their third-party business partners

The Price of Global Health

January 27, 2015

Defining 'market access'

A brightening outlook for pharma

November 03, 2014

The Impending AMP Rule, still waiting three years later

October 30, 2014

Some state-level changes give an indication of what to prepare for

Economic and clinical value: the future of cancer care

October 30, 2014

An 'expectations convergence' is building in how drug efficacy aligns with patient outcomes

Legal uncertainties in the DSCSA

August 29, 2014

The Drug Supply Chain Security Act creates uncertainty about which trading partners have responsibility for product verification

Is tech running you? Four ways to retake control

August 29, 2014

Modern training technologies make the prospect of days-long training courses an obsolete practice